FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older
Why It Matters: Older Adults Are at Higher Risk. Each year, about 60,000 adults 65 and older are hospitalized with R.S.V. and about 6,000 to 10,000 die from the virus, the F.D.A. estimated. The Centers for Disease Control and Prevention estimated that in one year, more than 21,000 people in that…
#rsv #fda #gsk #pfizer #abrysvo #arexvy #millerfisher #cdc #jericapitts #medicaid
